These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26052847)

  • 1. Trial sequential methods for meta-analysis.
    Kulinskaya E; Wood J
    Res Synth Methods; 2014 Sep; 5(3):212-20. PubMed ID: 26052847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial Sequential Analysis in systematic reviews with meta-analysis.
    Wetterslev J; Jakobsen JC; Gluud C
    BMC Med Res Methodol; 2017 Mar; 17(1):39. PubMed ID: 28264661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of multiple endpoint dependency on Q and I(2) in meta-analysis.
    Thompson CG; Becker BJ
    Res Synth Methods; 2014 Sep; 5(3):235-53. PubMed ID: 26052849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A finite mixture method for outlier detection and robustness in meta-analysis.
    Beath KJ
    Res Synth Methods; 2014 Dec; 5(4):285-93. PubMed ID: 26052953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial sequential analyses of meta-analyses of complications in laparoscopic vs. small-incision cholecystectomy: more randomized patients are needed.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    J Clin Epidemiol; 2010 Mar; 63(3):246-56. PubMed ID: 20004553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses.
    Brok J; Thorlund K; Wetterslev J; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):287-98. PubMed ID: 18824466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.
    Brok J; Thorlund K; Gluud C; Wetterslev J
    J Clin Epidemiol; 2008 Aug; 61(8):763-9. PubMed ID: 18411040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of two-way linear mixed models in multitreatment meta-analysis.
    Piepho HP; Williams ER; Madden LV
    Biometrics; 2012 Dec; 68(4):1269-77. PubMed ID: 22845838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis and the reversed Theorem of the Means.
    Edwardes MD
    Res Synth Methods; 2014 Dec; 5(4):313-21. PubMed ID: 26052955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size re-estimation for adaptive sequential design in clinical trials.
    Gao P; Ware JH; Mehta C
    J Biopharm Stat; 2008; 18(6):1184-96. PubMed ID: 18991116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-CART: A tool to identify interactions between moderators in meta-analysis.
    Li X; Dusseldorp E; Meulman JJ
    Br J Math Stat Psychol; 2017 Feb; 70(1):118-136. PubMed ID: 28130936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three methods for constructing parallel gatekeeping procedures in clinical trials.
    Dmitrienko A; Soulakova JN; Millen BA
    J Biopharm Stat; 2011 Jul; 21(4):768-86. PubMed ID: 21516568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of a continuous outcome combining individual patient data and aggregate data: a method based on simulated individual patient data.
    Yamaguchi Y; Sakamoto W; Goto M; Staessen JA; Wang J; Gueyffier F; Riley RD
    Res Synth Methods; 2014 Dec; 5(4):322-51. PubMed ID: 26052956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.
    Wetterslev J; Thorlund K; Brok J; Gluud C
    J Clin Epidemiol; 2008 Jan; 61(1):64-75. PubMed ID: 18083463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.